Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors.

Adamczyk M, Brashear RJ, Mattingly PG.

Clin Chem. 2010 Apr;56(4):676-7. doi: 10.1373/clinchem.2009.138099. Epub 2010 Jan 21. No abstract available.

2.

Circulating cardiac troponin-I autoantibodies in human plasma and serum.

Adamczyk M, Brashear RJ, Mattingly PG.

Ann N Y Acad Sci. 2009 Sep;1173:67-74. doi: 10.1111/j.1749-6632.2009.04617.x.

PMID:
19758134
3.

Prevalence of autoantibodies to cardiac troponin T in healthy blood donors.

Adamczyk M, Brashear RJ, Mattingly PG.

Clin Chem. 2009 Aug;55(8):1592-3. doi: 10.1373/clinchem.2009.125781. Epub 2009 Jun 4. No abstract available.

4.

Homogeneous chemiluminescent assays for free choline in human plasma and whole blood.

Adamczyk M, Brashear RJ, Mattingly PG, Tsatsos PH.

Anal Chim Acta. 2006 Oct 2;579(1):61-7. Epub 2006 Jul 14.

PMID:
17723728
5.

Choline concentration in normal blood donor and cardiac troponin-positive plasma samples.

Adamczyk M, Brashear RJ, Mattingly PG.

Clin Chem. 2006 Nov;52(11):2123-4. No abstract available.

6.

Rapid high-throughput detection of peroxide with an acridinium-9-carboxamide: a homogeneous chemiluminescent assay for plasma choline.

Adamczyk M, Brashear RJ, Mattingly PG.

Bioorg Med Chem Lett. 2006 May 1;16(9):2407-10. Epub 2006 Feb 17.

PMID:
16487704
7.

Chemiluminescent acridinium-9-carboxamide boronic acid probes: application to a homogeneous glycated hemoglobin assay.

Adamczyk M, Chen YY, Johnson DD, Mattingly PG, Moore JA, Pan Y, Reddy RE.

Bioorg Med Chem Lett. 2006 Mar 1;16(5):1324-8. Epub 2005 Dec 15.

PMID:
16343903
8.

Intrinsic factor-mediated modulation of cyanocobalamin-N-sulfonyl-acridinium-9-carboxamide chemiluminescence.

Adamczyk M, Johnson DD, Mattingly PG, Moore JA, Pan Y.

Bioorg Med Chem Lett. 2004 Aug 2;14(15):3917-21.

PMID:
15225697
9.

Chemiluminescence quenching of pteroic acid-N-sulfonyl-acridinium-9-carboxamide conjugates by folate binding protein.

Adamczyk M, Fino JR, Mattingly PG, Moore JA, Pan Y.

Bioorg Med Chem Lett. 2004 May 3;14(9):2313-7.

PMID:
15081031
10.

Regiodependent luminescence quenching of biotinylated N-sulfonyl-acridinium-9-carboxamides by avidin.

Adamczyk M, Mattingly PG, Moore JA, Pan Y.

Org Lett. 2003 Oct 16;5(21):3779-82.

PMID:
14535708
11.

Design of acridinium-9-carboxamides and anti-acridinium antibodies for chemiluminescent signal enhancement.

Adamczyk M, Mattingly PG, Moore JA, Pan Y, Shreder K, Yu Z.

Bioconjug Chem. 2001 May-Jun;12(3):329-31.

PMID:
11353528
12.

Evidence of nucleophilic addition to chemiluminescent N-sulfonylacridinium-9-carboxamides from electrospray ionization mass spectrometry.

Adamczyk M, Gebler JC, Mattingly PG, Wu J.

Rapid Commun Mass Spectrom. 2000;14(22):2112-5.

PMID:
11114017
13.

Linker-mediated modulation of the chemiluminescent signal from N(10)-(3-Sulfopropyl)-N-sulfonylacridinium-9-carboxamide tracers.

Adamczyk M, Chen YY, Fishpaugh JR, Mattingly PG, Pan Y, Shreder K, Yu Z.

Bioconjug Chem. 2000 Sep-Oct;11(5):714-24.

PMID:
10995216
14.
15.

Synthesis of a chemiluminescent acridinium hydroxylamine (AHA) for the direct detection of abasic sites in DNA.

Adamczyk M, Mattingly PG, Moore JA, Pan Y.

Org Lett. 1999 Sep 9;1(5):779-81.

PMID:
10823204
16.

Synthesis of 5- and 6-hydroxymethylfluorescein phosphoramidites.

Adamczyk M, Chan CM, Fino JR, Mattingly PG.

J Org Chem. 2000 Jan 28;65(2):596-601. No abstract available.

PMID:
10813979
17.

Evaluation of chemiluminescent estradiol conjugates by using a surface plasmon resonance detector.

Adamczyk M, Chen YY, Gebler JC, Johnson DD, Mattingly PG, Moore JA, Reddy RE, Wu J, Yu Z.

Steroids. 2000 Jun;65(6):295-303.

PMID:
10802280
18.

Surface plasmon resonance (SPR) as a tool for antibody conjugate analysis.

Adamczyk M, Mattingly PG, Shreder K, Yu Z.

Bioconjug Chem. 1999 Nov-Dec;10(6):1032-7.

PMID:
10563772
19.
20.

Resin-supported labeling reagents.

Adamczyk M, Fishpaugh JR, Mattingly PG.

Bioorg Med Chem Lett. 1999 Jan 18;9(2):217-20.

PMID:
10021932
21.

O-(fluoresceinylmethyl)hydroxylamine (OFMHA): a fluorescent reagent for detection of damaged nucleic acids.

Adamczyk M, Mattingly PG, Moore JA.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3599-602.

PMID:
9934478
22.

Tracermer signal generators: an arborescent approach to the incorporation of multiple chemiluminescent labels.

Adamczyk M, Fishpaugh J, Mattingly PG, Shreder K.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3595-8.

PMID:
9934477
23.

Estradiol-mimetic probes. Preparation of 17 alpha-(6-aminohexynyl)estradiol biotin, fluorescein and acridinium conjugates.

Adamczyk M, Chen YY, Moore JA, Mattingly PG.

Bioorg Med Chem Lett. 1998 Jun 2;8(11):1281-4.

PMID:
9871750
24.

Synthesis of 6 beta-aminoestradiol and its biotin, acridinium, and fluorescein conjugates.

Adamczyk M, Mattingly PG, Reddy RE.

Steroids. 1998 Mar;63(3):130-4.

PMID:
9558712
26.
28.
29.

A convenient method for the preparation of hapten phosphoramidites.

Fino JR, Mattingly PG, Ray KA.

Bioconjug Chem. 1996 Mar-Apr;7(2):274-80.

PMID:
8983351
30.

Digoxin dialdehyde reductive aminations. Structure proof of the perhydro-1,4-oxazepine product.

Adamczyk M, Grote J, Mattingly PG.

Steroids. 1995 Nov;60(11):753-8.

PMID:
8585099
31.

Immunoassay reagents for thyroid testing. 1. Synthesis of thyroxine conjugates.

Adamczyk M, Fino L, Fishpaugh JR, Johnson DD, Mattingly PG.

Bioconjug Chem. 1994 Sep-Oct;5(5):459-62.

PMID:
7849077
32.

Preparation of 5- and 6-(aminomethyl)fluorescein.

Mattingly PG.

Bioconjug Chem. 1992 Sep-Oct;3(5):430-1.

PMID:
1420443
33.

Supplemental Content

Loading ...
Support Center